Top practices for implementing cabotegravir (CAB) and rilpivirine (RPV) long-acting (LA) in European clinics

Julian Olalla; Cassidy Gutner; Miguel Pascual-Bernaldez; Beatriz Hernandez; Samia Dakhia; Laurence Slama; Maria Jose Crusells Canales; Thomas Lutz; Mark van der Valk; Berend van Welzen; Eric Florence; Nicola Barnes; Owen Cooper; Dina Filipenko; Maggie Czarnogorski

doi:10.1111/hiv.13286

Top practices for implementing cabotegravir (CAB) and rilpivirine (RPV) long-acting (LA) in European clinics

Julian Olalla
, Cassidy Gutner
, Miguel Pascual-Bernaldez
, Beatriz Hernandez
, Samia Dakhia
, Laurence Slama
, Maria Jose Crusells Canales
, Thomas Lutz
, Mark van der Valk
, Berend van Welzen
, Eric Florence
, Nicola Barnes
, Owen Cooper
, Dina Filipenko
, Maggie Czarnogorski

Research output: Contribution to journal › Meeting abstract in journal

Original language	English
Article number	P008
Journal	HIV Medicine
Volume	23
Issue number	S2
Pages (from-to)	27-28
Number of pages	2
ISSN	1464-2662
DOIs	https://doi.org/10.1111/hiv.13286
Publication status	Published - 2022

Access to Document

10.1111/hiv.13286

Cite this

Olalla, J., Gutner, C., Pascual-Bernaldez, M., Hernandez, B., Dakhia, S., Slama, L., Crusells Canales, M. J., Lutz, T., van der Valk, M., van Welzen, B., Florence, E., Barnes, N., Cooper, O., Filipenko, D., & Czarnogorski, M. (2022). Top practices for implementing cabotegravir (CAB) and rilpivirine (RPV) long-acting (LA) in European clinics. HIV Medicine, 23(S2), 27-28. Article P008. https://doi.org/10.1111/hiv.13286

@article{128d3565bde8458eb2621edec66a2be5,

title = "Top practices for implementing cabotegravir (CAB) and rilpivirine (RPV) long-acting (LA) in European clinics",

author = "Julian Olalla and Cassidy Gutner and Miguel Pascual-Bernaldez and Beatriz Hernandez and Samia Dakhia and Laurence Slama and \{Crusells Canales\}, \{Maria Jose\} and Thomas Lutz and \{van der Valk\}, Mark and \{van Welzen\}, Berend and Eric Florence and Nicola Barnes and Owen Cooper and Dina Filipenko and Maggie Czarnogorski",

note = "NPP: FTX Abonnement",

year = "2022",

doi = "10.1111/hiv.13286",

language = "English",

volume = "23",

pages = "27--28",

journal = "HIV Medicine",

issn = "1464-2662",

publisher = "John Wiley \& Sons",

number = "S2",

}

Olalla, J, Gutner, C, Pascual-Bernaldez, M, Hernandez, B, Dakhia, S, Slama, L, Crusells Canales, MJ, Lutz, T, van der Valk, M, van Welzen, B, Florence, E, Barnes, N, Cooper, O, Filipenko, D & Czarnogorski, M 2022, 'Top practices for implementing cabotegravir (CAB) and rilpivirine (RPV) long-acting (LA) in European clinics', HIV Medicine, vol. 23, no. S2, P008, pp. 27-28. https://doi.org/10.1111/hiv.13286

TY - JOUR

T1 - Top practices for implementing cabotegravir (CAB) and rilpivirine (RPV) long-acting (LA) in European clinics

AU - Olalla, Julian

AU - Gutner, Cassidy

AU - Pascual-Bernaldez, Miguel

AU - Hernandez, Beatriz

AU - Dakhia, Samia

AU - Slama, Laurence

AU - Crusells Canales, Maria Jose

AU - Lutz, Thomas

AU - van der Valk, Mark

AU - van Welzen, Berend

AU - Florence, Eric

AU - Barnes, Nicola

AU - Cooper, Owen

AU - Filipenko, Dina

AU - Czarnogorski, Maggie

N1 - NPP: FTX Abonnement

PY - 2022

Y1 - 2022

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000786450500039

U2 - 10.1111/hiv.13286

DO - 10.1111/hiv.13286

M3 - Meeting abstract in journal

SN - 1464-2662

VL - 23

SP - 27

EP - 28

JO - HIV Medicine

JF - HIV Medicine

IS - S2

M1 - P008

ER -

Top practices for implementing cabotegravir (CAB) and rilpivirine (RPV) long-acting (LA) in European clinics

Access to Document

Other files and links

Cite this